Year: 2017
Type: dissertation
Abstract: Triple-negative breast cancer (TNBC) represents 20% of breast cancer and patients receive only general chemotherapy. The epidermal growth factor receptor (EGFR) is commonly expressed in TNBC and it is associated with poor prognosis. Fatty acid synthase (FASN) is overexpressed in cancer and its inhibition causes apoptosis in cancer cells. This thesis shows that FASN is overexpressed in TNBC, and its expression is associated with poor disease progression. In addition, FASN not only may have a role in cancer progression but also in resistance acquisition. Finally, the dual inhibition of EGFR and FASN shows synergistic outcome in all pre-clinical models both sensitive and resistant models of TNBC. These results may serve as a basis for the development of new pharmacological strategies by inhibiting FASN alone or in combination in TNBC.
Author: Ariadna Giró Perafita
Institution: Universitat de Girona
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2737865551
